31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Parkinson's Disease

Clinical trial NCT03815916 · COMPLETED

Trial details

NCT number: NCT03815916
Sponsor: Clene Nanomedicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2019-12-19
Primary completion: 2021-06-07
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.